Articles by Patricia Van Arnum - BioPharm International



Articles by Patricia Van Arnum

Patricia Van Arnum

Biogen Idec, Samsung Bioepis Target Anti-TNF Biosimilars in Europe
December 18, 2013

Biogen and Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, advance plans for anti-TNF biosimilar product candidates.

AstraZeneca Issues Statement on Competitor to Nexium
December 18, 2013

AstraZeneca issues a statement regarding the launch of esomeprazole strontium in the United States.

Pfizer, Teva Settle Patent Litigation on Viagra
December 18, 2013

Pfizer settles its litigation against Teva Pharmaceuticals regarding Pfizer's patent covering the use of Viagra.

GlaxoSmithKline To Invest in UK-Based Manufacturing
December 12, 2013

GlaxoSmithKline plans to expand its facilities in Ware and Worthing in the United Kingdom and will build a new facility for manufacturing innovation.

Roche, Prothena Form mAb Pact
December 12, 2013

Roche and Prothena sign deal worth up to $600 million to develop and commercialize antibodies that target alpha-synuclein.

Teva Releases Financial Guidance Dependent on Copaxone Generic Competition
December 12, 2013

Teva Pharmaceutical Industries releases a financial outlook for 2014 based on two possible scenarios concerning its multiple-sclerosis drug Copaxone (glatiramer acetate).

Pharmaceutical Industry Growth Rebounds in Five-Year Outlook
November 22, 2013

Annual growth in spending for medicines is expected to rise from 2-3% in 2013 to 5-7% in 2017, the highest pace of growth since 2009.

AstraZeneca, Bristol-Myers Squibb Recall Certain Lots of Bydureon
September 24, 2013

AstraZeneca, Bristol-Myers Squibb recall certain lots of of their antidiabetes drug Bydureon (eventide) due to manufacturing records that batches may contain underfilled vials.

Elan Proceeds with Formal Sale Process of Company; Royalty Pharma Drops Bid
June 19, 2013

The move follows rejection of Elan shareholders of certain key deals and withdrawal of Royalty Pharma bid.



Click here